News
BBLG
1.400
+4.48%
0.060
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 4d ago
Weekly Report: what happened at BBLG last week (0615-0619)?
Weekly Report · 5d ago
Weekly Report: what happened at BBLG last week (0608-0612)?
Weekly Report · 06/15 10:14
Weekly Report: what happened at BBLG last week (0601-0605)?
Weekly Report · 06/08 10:10
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Benzinga · 06/08 10:05
Weekly Report: what happened at BBLG last week (0525-0529)?
Weekly Report · 06/01 10:14
Weekly Report: what happened at BBLG last week (0518-0522)?
Weekly Report · 05/25 10:17
Bone Biologics achieves 29-month shelf life for rhNELL-1
TipRanks · 05/19 12:10
Bone Biologics Announces Validated Shelf Life Extension Of Its rhNELL-1 Protein Product To 29 Months
Benzinga · 05/19 12:07
Weekly Report: what happened at BBLG last week (0511-0515)?
Weekly Report · 05/18 10:17
Bone Biologics Q1 EPS $(0.43) Beats $(0.54) Estimate
Benzinga · 05/14 21:11
Bone Biologics Q1 FY26 net loss narrows 24.69% to $765,988
PUBT · 05/14 21:02
Weekly Report: what happened at BBLG last week (0504-0508)?
Weekly Report · 05/11 10:14
Weekly Report: what happened at BBLG last week (0427-0501)?
Weekly Report · 05/04 10:12
Weekly Report: what happened at BBLG last week (0420-0424)?
Weekly Report · 04/27 10:14
Weekly Report: what happened at BBLG last week (0413-0417)?
Weekly Report · 04/20 10:11
Weekly Report: what happened at BBLG last week (0406-0410)?
Weekly Report · 04/13 10:14
Weekly Report: what happened at BBLG last week (0330-0403)?
Weekly Report · 04/06 10:15
Weekly Report: what happened at BBLG last week (0323-0327)?
Weekly Report · 03/30 10:15
Weekly Report: what happened at BBLG last week (0316-0320)?
Weekly Report · 03/23 10:12
More
Webull provides a variety of real-time BBLG stock news. You can receive the latest news about Bone Biologics Corp through multiple platforms. This information may help you make smarter investment decisions.
About BBLG
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.